EverSource Wealth Advisors, LLC

Position in HCM — HUTCHMED (China) Ltd

CIK 1710537 BIRMINGHAM, AL

Back to HCM Full portfolio

Position in HCM

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$5,144

+$1,933 QoQ

Shares Held

344

+42.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#41

of 54 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in HCM Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

EverSource Wealth Advisors, LLC holds $3,753,691 across 50 Drug Manufacturers - Specialty & Generic names. HCM ranks #30 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	4,557	$600,332
2	HLN	Haleon plc	57,526	$575,830
3	TAK	Takeda Pharmaceutical Co Ltd	25,896	$479,586
4	PAHC	Phibro Animal Health Corp	5,907	$326,712
5	ZTS	Zoetis Inc.	2,285	$270,103
6	SUPN	Supernus Pharmaceuticals, Inc.	4,859	$251,159
7	ELAN	Elanco Animal Health Inc	9,415	$225,295
8	COLL	Collegium Pharmaceutical, Inc	5,035	$166,503

All Filings in HCM

Export CSV

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,144	344	+42.7%	Shares	Sole	2026-05-18
2025-12-31	$3,211	241	-48.2%	Shares	Sole	2026-02-06
2025-09-30	$7,323	465	+43.1%	Shares	Sole	2025-11-10
2025-06-30	$4,891	325	-57.4%	Shares	Sole	2025-08-13
2025-03-31	$11,475	763	+40.8%	Shares	Sole	2025-05-13
2024-12-31	$7,809	542	-29.0%	Shares	Sole	2025-02-10
2024-09-30	$14,900	763	+12.2%	Shares	Sole	2024-11-08
2024-06-30	$11,641	680	+690.7%	Shares	Sole	2024-08-13
2024-03-31	$1,444	86	+19.4%	Shares	Sole	2024-06-11
2023-12-31	$1,303	72	-32.1%	Shares	Sole	2024-02-09
2023-09-30	$1,794	106	+10.4%	Shares	Sole	2023-11-03
2021-12-31	$3,367	96	—	Shares	Sole	2022-02-17
No filing history on record for this holder in this stock.